Filings

ASX Filings

Date	Description
April 4, 2024	Opthea Appoints Sujal Shah to the Board of Directors
April 4, 2024	Opthea Key Opinion Leader Even on Sozinibercept
April 2, 2024	Notification regarding unquoted securities - OPT
March 19, 2024	Opthea to Host Key Opinion Leader Event on April 3, 2024
March 6, 2024	Opthea to Participate in Leerink Global Biopharma Conference

There are no SEC filings available.

Data provided by Kaleidoscope.